BioCentury
ARTICLE | Clinical News

Seroquel XL quetiapine regulatory update

October 4, 2010 7:00 AM UTC

AstraZeneca said the U.K. approved once-daily Seroquel XL quetiapine as an add-on to treat major depressive episodes in major depressive disorder (MDD) patients who have sub-optimal response to antide...